Press Releases
Financial Summary:
- Net sales were
$35.2 million in the quarter, an increase of$6.4 million , or 22.3%, compared to third quarter 2012 sales of$28.8 million . Upgrades by numerous law enforcement agencies to the new TASER® X26P™ and TASER X2™ Smart Weapons drove the increase. AXON® cameras, EVIDENCE.com and TASER® CAM™ HD recorders also contributed to the net sales increase in the third quarter.
- TASER Weapons segment revenues grew
$4.5 million year-over-year, or 16.8%, to$31.6 million in the third quarter of 2013.
- EVIDENCE.com and Video product revenues increased by
$1.9 million , or 111.5%, to$3.6 million in the third quarter of 2013.
- Gross margin in the third quarter of 2013 was 62.8%, compared to 58.4% in the same period last year. The improvement in gross margin in the third quarter of 2013 was driven by the 22.3% increase in net sales which resulted in better leverage of overhead expense, increased sales prices and lower trade-in credit values. Gross margin continues to benefit from the Company's decision to utilize third-party cloud services in its Video segment. Gross margin also benefited from the full depreciation of the capitalized EVIDENCE.com software development costs.
- Sales, general and administrative (SG&A) expenses of
$12.8 million in the third quarter of 2013 increased 33.9%, from$9.5 million in the third quarter of 2012. As a percentage of revenue, SG&A increased to 36.3% in the third quarter 2013 compared to 33.2% in the prior year. The increase to SG&A was primarily driven by professional, accounting and legal fees and litigation expenses which increased$2.2 million compared to the prior year primarily due to expenses relating to the defense of product and commercial litigation. The Company expects expenses relating to the defense of product and commercial litigation to trend downward in the second half of 2014. Also contributing to the increase in SG&A, personnel expenses increased$0.7 million year-over-year due to the Company's strategic effort to enhance its customer-facing capabilities in roles such as account management and telesales, in addition to some incremental administrative functions. Finally, we incurred higher selling and marketing expenses of approximately$0.4 million to support our initiatives internationally and in the video market.
- Research and development (R&D) expenses of
$2.4 million for the third quarter of 2013 increased$0.5 million , or 22.9%, when compared to the third quarter of 2012 primarily driven by additional personnel expense related to EVIDENCE.com and Video product segment development initiatives. The Company expects to see increased expenses in R&D through 2014 as EVIDENCE.com scales and we begin to expand our cloud offerings into adjacent technologies in law enforcement.
- Income from operations increased
$1.6 million , or 30.4%, to$6.9 million in the third quarter of 2013 compared to the third quarter of 2012.
- Adjusted EBITDA was
$9.0 million for the third quarter of 2013, an increase from Adjusted EBITDA of$8.0 million in the third quarter of 2012. The increase is due to increased sales and margins.
- Net income for the third quarter of 2013 was
$5.1 million , or$0.10 per basic and diluted share.
- In the third quarter of 2013, the Company generated
$10.9 million in cash from operating activities. Cash, cash equivalents and investments were$48.3 million at the end of the third quarter of 2013, up from$37.8 million atDecember 31, 2012 .
"These are exciting times for us as our long-term business strategy is now intersecting several trends which we believe have hit a tipping point, namely officer-worn video and cloud computing," said
"The last few months have been full of momentous events for the Company including the launch of the AXON body™ camera, the Familiar team acquisition, the announcement of the EVIDENCE Mobile application all culminating in record quarterly revenues," said
Other Significant Events:
- The Company announced a number of significant orders for its Smart Weapons, the new X26P and the X2 that occurred during the third quarter, including:
Chesterfield County Police Department (VA) purchased 80 X2sCumberland County Sheriff's Office (NC) purchased 175 X26PsDeKalb County Police Department (GA) purchased 150 X26PsFayetteville Police Department (NC) purchased 200 X2sForsyth County Sheriff's Office (NC) purchased 100 X2s with TASER CAM HD recordersHouston Police Department (TX) purchased 2,188 X2sJacksonville Sheriff's Office (FL) purchased 80 X26PsJefferson Parish Sheriff's Office (LA) purchased 700 X26Ps and TASER CAM HD recordersLas Vegas Metro Police Department (NV) purchased 174 X26PsManatee County Sheriff's Office (FL) purchased 100 X26PsMargate Police Department (FL) purchased 103 X2sMaricopa County Sheriff's Office (AZ) purchased 577 X2s and TASER CAM HD recordersMilwaukee Police Department (WI) purchased 130 X2sRhode Island State Police (RI) purchased 170 X26PsRiviera Beach Police Department (FL) purchased 90 X2sU.S. Forest Service purchased 400 X26Ps- Two additional U.S. law enforcement agencies purchased a combined 837 X2s
- The Company continued to see new agencies adopt the AXON flex and new AXON body on-officer cameras and EVIDENCE.com management service during the third quarter. AXON and EVIDENCE.com deployments included significant orders from:
Albuquerque Police Department (NM)Brookfield Police Department (WI)Dallas Fort Worth International Airport Department of Public Safety (TX)Fort Worth Police Department (TX)Greensboro Police Department (NC)Spokane Police Department (WA)Surprise Police Department (AZ)Topeka Police Department (KS)
- Subsequent to the close of the third quarter, the Company announced the acquisition of
Familiar, Inc. as a move to enhance the R&D efforts around EVIDENCE.com and to expand our mobile offerings into additional adjacent markets within public safety.
- The Company will continue to take questions relating to the third quarter results via social media. TASER management will entertain questions during the call asked via Twitter, in addition to questions from those logged into the webcast. Individuals may submit questions via Twitter using hashtag #TASR_Earnings to the @TASER_IR handle. TASER management regrets that due to time considerations, not all questions may be answered during the call. For those individuals who do not have access to Twitter, all tweets and related content are streamed directly to http://investor.taser.com.
- The Company will update its investor relations presentation and fact sheet and post them to http://investor.taser.com within the next two weeks with the third quarter results. Archived presentations from previous quarters may also be found on the website.
The Company will host its third quarter 2013 earnings conference call on
Non-GAAP Measures
To supplement the Company's financial results presented in accordance with GAAP, we are presenting the non-GAAP financial measures of EBITDA and Adjusted EBITDA. Our management uses these non-GAAP financial measures in evaluating the Company's performance in comparison to prior periods and as a measure of liquidity. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning and forecasting our future periods. A reconciliation of GAAP to the non-GAAP financial measures is presented at the end of the release.
EBITDA is defined as consolidated net income (loss) before interest expense, income taxes and depreciation and amortization. Adjusted EBITDA as presented herein is defined as EBITDA before certain other items, including: stock-based compensation; loss on write-down/disposal of property, equipment and intangibles, net; provision for obsolete and excess inventory; litigation judgment (reversal) expense; loss on impairment; and interest income and other (income) expense.
Caution on Use of Non-GAAP Measures
These non-GAAP financial measures are not consistent with GAAP, and management believes investors will benefit by referring to these non-GAAP financial measures when assessing the Company's operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:
- these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company's GAAP financial measures;
- these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company's GAAP financial measures;
- these non-GAAP financial measures should not be considered to be superior to the Company's GAAP financial measures; and
- these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principles.
Further, these non-GAAP financial measures may be unique to the Company, as they may be different from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company's results to the results of other companies.
A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure or measures appears within this press release.
About
TASER® is a registered trademark of
Note to Investors
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding our expectations, beliefs, intentions or strategies regarding the future; that we expect to see increased R&D expenses in 2014; and that we will continue to invest in EVIDENCE.com. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding
Please visit http://investor.taser.com, http://blog.taser.com, www.twitter.com/taser_ir, www.twitter.com/officialtaser and http://www.facebook.com/TASERInternational where TASER discloses information from time to time about the company, its financial information, and its business.
For investor relations information please contact
TASER International, Inc. | ||||||||||||||
Consolidated Statements of Operations | ||||||||||||||
(Unaudited) | ||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||
Net sales | $ | 35,196,822 | $ | 28,772,956 | $ | 97,806,271 | $ | 82,636,791 | ||||||
Cost of products sold and services delivered | 13,100,817 | 11,969,944 | 37,516,899 | 34,090,148 | ||||||||||
Gross margin | 22,096,005 | 16,803,012 | 60,289,372 | 48,546,643 | ||||||||||
Sales, general and administrative expenses | 12,775,980 | 9,539,996 | 34,898,005 | 26,798,629 | ||||||||||
Research and development expenses | 2,439,812 | 1,985,701 | 6,444,432 | 6,156,751 | ||||||||||
Litigation judgment recovery | - | - | - | (2,200,000 | ) | |||||||||
Income from operations | 6,880,213 | 5,277,315 | 18,946,935 | 17,791,263 | ||||||||||
Interest and other income (expense), net | 34,891 | 11,418 | 30,807 | 25,545 | ||||||||||
Income before provision for income taxes | 6,915,104 | 5,288,733 | 18,977,742 | 17,816,808 | ||||||||||
Provision for income taxes | 1,801,512 | 1,611,861 | 6,108,795 | 6,893,872 | ||||||||||
Net income | $ | 5,113,592 | $ | 3,676,872 | $ | 12,868,947 | $ | 10,922,936 | ||||||
Income per common and common equivalent shares | ||||||||||||||
Basic | $ | 0.10 | $ | 0.07 | $ | 0.25 | $ | 0.19 | ||||||
Diluted | $ | 0.10 | 0.07 | 0.24 | 0.19 | |||||||||
Weighted average number of common and common equivalent shares outstanding | ||||||||||||||
Basic | 51,341,785 | 52,509,068 | 51,727,197 | 57,997,341 | ||||||||||
Diluted | 53,320,918 | 53,106,325 | 53,643,803 | 58,482,833 | ||||||||||
TASER International, Inc. |
Segment Reporting |
(Unaudited) |
Three Months Ended |
Three Months Ended |
||||||||||||||||||||||
TASER Weapons | EVIDENCE.com & Video |
Total | TASER Weapons | EVIDENCE.com & Video |
Total | ||||||||||||||||||
Product sales | $ | 31,626,484 | $ | 3,103,781 | $ | 34,730,265 | $ | 27,085,180 | $ | 1,528,347 | $ | 28,613,527 | |||||||||||
Service revenue | - | 466,557 | 466,557 | - | 159,429 | 159,429 | |||||||||||||||||
Net sales | 31,626,484 | 3,570,338 | 35,196,822 | 27,085,180 | 1,687,776 | 28,772,956 | |||||||||||||||||
Cost of products sold | 10,906,999 | 1,896,691 | 12,803,690 | 9,673,370 | 1,181,906 | 10,855,276 | |||||||||||||||||
Cost of services delivered | - | 297,127 | 297,127 | - | 1,114,668 | 1,114,668 | |||||||||||||||||
Gross margin | 20,719,485 | 1,376,520 | 22,096,005 | 17,411,810 | (608,798 | ) | 16,803,012 | ||||||||||||||||
Sales, general & administrative | 11,130,971 | 1,645,009 | 12,775,980 | 8,618,250 | 921,746 | 9,539,996 | |||||||||||||||||
Research & development | 1,160,400 | 1,279,412 | 2,439,812 | 1,043,607 | 942,094 | 1,985,701 | |||||||||||||||||
Income (loss) from operations | $ | 8,428,114 | $ | (1,547,901 | ) | $ | 6,880,213 | $ | 7,749,953 | $ | (2,472,638 | ) | $ | 5,277,315 | |||||||||
Operating margin % | 27 | % | -43 | % | 20 | % | 29 | % | -147 | % | 18 | % | |||||||||||
Nine Months Ended |
Nine Months Ended |
||||||||||||||||||||||
TASER Weapons | EVIDENCE.com & Video |
Total | TASER Weapons | EVIDENCE.com & Video |
Total | ||||||||||||||||||
Product sales | $ | 89,901,959 | $ | 6,853,388 | $ | 96,755,347 | $ | 78,774,581 | $ | 3,464,606 | $ | 82,239,187 | |||||||||||
Service revenue | - | 1,050,924 | 1,050,924 | - | 397,604 | 397,604 | |||||||||||||||||
Net sales | 89,901,959 | 7,904,312 | 97,806,271 | 78,774,581 | 3,862,210 | 82,636,791 | |||||||||||||||||
Cost of products sold | 31,534,576 | 4,440,236 | 35,974,812 | 28,068,676 | 2,712,678 | 30,781,354 | |||||||||||||||||
Cost of services delivered | - | 1,542,087 | 1,542,087 | - | 3,308,794 | 3,308,794 | |||||||||||||||||
Gross margin | 58,367,383 | 1,921,989 | 60,289,372 | 50,705,905 | (2,159,262 | ) | 48,546,643 | ||||||||||||||||
Sales, general & administrative | 30,622,109 | 4,275,896 | 34,898,005 | 24,373,401 | 2,425,228 | 26,798,629 | |||||||||||||||||
Research & development | 3,126,589 | 3,317,843 | 6,444,432 | 2,806,043 | 3,350,708 | 6,156,751 | |||||||||||||||||
Litigation judgment recovery | - | - | - | (2,200,000 | ) | - | (2,200,000 | ) | |||||||||||||||
Income (loss) from operations | $ | 24,618,685 | $ | (5,671,750 | ) | $ | 18,946,935 | $ | 25,726,461 | $ | (7,935,198 | ) | $ | 17,791,263 | |||||||||
Operating margin % | 27 | % | -72 | % | 19 | % | 33 | % | -205 | % | 22 | % | |||||||||||
TASER International, Inc. | ||||||||||||||
AXONFlex and EVIDENCE.COM Bookings by Quarter | ||||||||||||||
(Unaudited) | ||||||||||||||
For the Quarter ended, | ||||||||||||||
2013 |
2013 |
2013 |
2012 |
2012 |
||||||||||
Bookings | $ | 5,846,547 | $ | 2,045,938 | $ | 1,387,199 | $ | 1,670,813 | $ | 1,318,107 | ||||
AXON Flex and EVIDENCE.com Bookings is a statistical measure defined as the sales price of orders placed in the relevant time period. Bookings is an indication of the activity the Company is seeing relative to AXON Flex and EVIDENCE.com.
The Company has deliverables to meet, prior to recognizing revenue related to many of the orders. These statistics represent orders and not invoiced sales. Once invoiced, the revenue related to EVIDENCE.com is recognized over the requisite service period of one to five years. Due to municipal government funding rules, certain of the future year amounts included in bookings are subject to budget appropriation. Although TASER has entered into contracts for the delivery of products and services in the future and anticipates the contracts will be completed, if agencies do not appropriate money in future year budgets, revenue associated with these bookings will not ultimately be recognized, resulting in a future reduction to bookings.
For more information relative to our revenue recognition policies, please reference our
TASER International, Inc. | |||||||||||||||||||
Unit Sales Statistics | |||||||||||||||||||
(Unaudited) | |||||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||||
2013 | 2012 | Unit Change | Percent Change | 2013 | 2012 | Unit Change | Percent Change | ||||||||||||
X26 | 7,195 | 8,312 | (1,117 | ) | -13.4 | % | 24,296 | 31,951 | (7,655 | ) | -24.0 | % | |||||||
X26P | 7,327 | - | 7,327 | 100.0 | % | 17,663 | - | 17,663 | 100.0 | % | |||||||||
X2 | 8,469 | 7,290 | 1,179 | 16.2 | % | 20,431 | 19,406 | 1,025 | 5.3 | % | |||||||||
M26 | 502 | 1,617 | (1,115 | ) | -69.0 | % | 1,638 | 3,258 | (1,620 | ) | -49.7 | % | |||||||
X3 | - | 36 | (36 | ) | -100.0 | % | 271 | 69 | 202 | 292.8 | % | ||||||||
C2 | 1,544 | 2,832 | (1,288 | ) | -45.5 | % | 5,869 | 8,594 | (2,725 | ) | -31.7 | % | |||||||
TASER Cam | 3,343 | 1,957 | 1,386 | 70.8 | % | 8,349 | 5,446 | 2,903 | 53.3 | % | |||||||||
Cartridges | 375,363 | 434,167 | (58,804 | ) | -13.5 | % | 1,153,825 | 1,167,253 | (13,428 | ) | -1.2 | % | |||||||
AXON flex | 1,217 | 1,263 | (46 | ) | -3.6 | % | 3,580 | 2,018 | 1,562 | 77.4 | % | ||||||||
AXON body | 774 | - | 774 | 100.0 | % | 774 | - | 774 | 100.0 | % | |||||||||
StrikeLight | 1,322 | - | 1,322 | 100.0 | % | 1,322 | - | 1,322 | 100.0 | % | |||||||||
TASER International, Inc. | ||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||||||||
(Unaudited) | ||||||||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||||||||
September 30, 2013 | September 30, 2012 | September 30, 2013 | September 30, 2012 | |||||||||||
Net income | $ | 5,113,592 | $ | 3,676,872 | $ | 12,868,947 | $ | 10,922,936 | ||||||
Depreciation and amortization | 1,088,071 | 1,718,546 | 4,036,337 | 5,113,989 | ||||||||||
Interest expense | 2,795 | 405 | 8,326 | 4,479 | ||||||||||
Provision for income taxes | 1,801,512 | 1,611,861 | 6,108,795 | 6,893,872 | ||||||||||
EBITDA | $ | 8,005,970 | $ | 7,007,684 | $ | 23,022,405 | $ | 22,935,276 | ||||||
Adjustments: | ||||||||||||||
Stock-based compensation expense | 962,994 | 849,388 | 2,905,635 | 2,197,050 | ||||||||||
Loss on write down/disposal of property, equipment and intangibles, net | 1,787 | 126,963 | 83,820 | 305,138 | ||||||||||
Provision for excess and obsolete inventory | 110,211 | 39,351 | 279,184 | 236,819 | ||||||||||
Litigation judgment recovery | - | - | - | (2,200,000 | ) | |||||||||
Interest income and other (income) expense | (37,686 | ) | (11,823 | ) | (39,133 | ) | (30,024 | ) | ||||||
Adjusted EBITDA | $ | 9,043,276 | $ | 8,011,563 | $ | 26,251,911 | $ | 23,444,259 | ||||||
Adjusted EBITDA as a percentage of net sales | 25.7 | % | 27.8 | % | 26.8 | % | 28.4 | % | ||||||
Composition of stock-based compensation: | ||||||||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||||||||
September 30, 2013 | September 30, 2012 | September 30, 2013 | September 30, 2012 | |||||||||||
Cost of products sold | $ | 49,632 | $ | 38,085 | $ | 133,500 | $ | 133,977 | ||||||
Sales, general and administrative expenses | 735,433 | 657,870 | 2,292,672 | 1,631,234 | ||||||||||
Research and development expenses | 177,929 | 153,433 | 479,463 | 431,839 | ||||||||||
$ | 962,994 | $ | 849,388 | $ | 2,905,635 | $ | 2,197,050 | |||||||
TASER International, Inc. | ||||||||||
Consolidated Balance Sheets | ||||||||||
(Unaudited) | ||||||||||
September 30, 2013 | December 31, 2012 | |||||||||
ASSETS | ||||||||||
Current Assets: | ||||||||||
Cash and cash equivalents | $ | 35,005,494 | $ | 36,126,791 | ||||||
Short-term investments | 8,751,409 | 1,680,958 | ||||||||
Accounts and notes receivable, net | 20,093,295 | 18,101,240 | ||||||||
Inventory | 12,289,360 | 10,993,209 | ||||||||
Prepaid expenses and other current assets | 4,859,631 | 2,754,331 | ||||||||
Deferred income tax assets, net | 9,450,523 | 9,395,987 | ||||||||
Total current assets | 90,449,712 | 79,052,516 | ||||||||
Property and equipment, net | 19,347,416 | 21,952,201 | ||||||||
Deferred income tax assets, net | 10,397,208 | 11,605,812 | ||||||||
Intangible assets, net | 3,360,355 | 3,317,169 | ||||||||
Long-term investments | 4,580,049 | - | ||||||||
Other assets | 357,512 | 308,553 | ||||||||
Total assets | $ | 128,492,252 | $ | 116,236,251 | ||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
Current Liabilities: | ||||||||||
Accounts payable | $ | 5,112,997 | $ | 6,222,904 | ||||||
Accrued liabilities | 8,180,852 | 7,065,085 | ||||||||
Current portion of deferred revenue | 6,317,899 | 4,287,305 | ||||||||
Customer deposits | 1,077,622 | 500,018 | ||||||||
Current portion of capital lease payable | 35,545 | 33,947 | ||||||||
Total current liabilities | 20,724,915 | 18,109,259 | ||||||||
Deferred revenue, net of current portion | 12,302,510 | 7,835,767 | ||||||||
Liability for unrecognized tax benefits | 3,074,447 | 2,902,896 | ||||||||
Other long-term liabilities | 169,116 | - | ||||||||
Long-term portion of capital lease payable | 76,423 | 103,283 | ||||||||
Total liabilities | 36,347,411 | 28,951,205 | ||||||||
Stockholders' Equity: | ||||||||||
Preferred stock | - | - | ||||||||
Common stock | 683 | 661 | ||||||||
Additional paid-in capital | 128,623,101 | 111,661,393 | ||||||||
Treasury stock | (92,202,810 | ) | (67,203,043 | ) | ||||||
Retained earnings | 55,752,014 | 42,883,067 | ||||||||
Accumulated other comprehensive loss | (28,147 | ) | (57,032 | ) | ||||||
Total stockholders' equity | 92,144,841 | 87,285,046 | ||||||||
Total liabilities and stockholders' equity | $ | 128,492,252 | $ | 116,236,251 | ||||||
TASER International, Inc. | ||||||||||||||||
Selected Consolidated Statement of Cash Flows Information | ||||||||||||||||
(Unaudited) | ||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
September 30, 2013 | September 30, 2012 | September 30, 2013 | September 30, 2012 | |||||||||||||
Net income | $ | 5,113,592 | $ | 3,676,872 | $ | 12,868,947 | $ | 10,922,936 | ||||||||
Depreciation and amortization | 1,088,071 | 1,718,546 | 4,036,337 | 5,113,989 | ||||||||||||
Stock-based compensation expense | 962,994 | 849,388 | 2,905,635 | 2,197,050 | ||||||||||||
Net cash provided by operating activities | 10,863,245 | 9,873,657 | 23,086,514 | 23,258,163 | ||||||||||||
Net cash provided by (used in) investing activities | (1,232,151 | ) | 1,644,865 | (13,236,410 | ) | 676,690 | ||||||||||
Net cash provided by (used in) financing activities | 6,302,552 | (3,523,811 | ) | (10,968,934 | ) | (19,265,477 | ) | |||||||||
Cash and cash equivalents, end of period | 35,005,494 | 25,965,711 | 35,005,494 | 25,965,711 | ||||||||||||
CONTACT:
Chief Financial Officer
(480) 905-2000
Source:
News Provided by Acquire Media